JP6470681B2 - 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ - Google Patents

乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ Download PDF

Info

Publication number
JP6470681B2
JP6470681B2 JP2015505056A JP2015505056A JP6470681B2 JP 6470681 B2 JP6470681 B2 JP 6470681B2 JP 2015505056 A JP2015505056 A JP 2015505056A JP 2015505056 A JP2015505056 A JP 2015505056A JP 6470681 B2 JP6470681 B2 JP 6470681B2
Authority
JP
Japan
Prior art keywords
breast cancer
expression
grade
biomarkers
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015505056A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015519043A5 (enExample
JP2015519043A (ja
Inventor
カール・アルネ・クリステル・ブーレバエック
シュリステル・ラーッス・ベルティル・ヴィングレン
Original Assignee
イムノヴィア・アクチエボラーグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イムノヴィア・アクチエボラーグ filed Critical イムノヴィア・アクチエボラーグ
Publication of JP2015519043A publication Critical patent/JP2015519043A/ja
Publication of JP2015519043A5 publication Critical patent/JP2015519043A5/ja
Application granted granted Critical
Publication of JP6470681B2 publication Critical patent/JP6470681B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
JP2015505056A 2012-04-10 2013-04-10 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ Expired - Fee Related JP6470681B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1206323.6A GB201206323D0 (en) 2012-04-10 2012-04-10 Methods and arrays for use in the same
PCT/IB2013/052858 WO2013153524A1 (en) 2012-04-10 2013-04-10 Methods for determining a breast cancer-associated disease state and arrays for use in the methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018187868A Division JP2019032334A (ja) 2018-10-03 2018-10-03 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ

Publications (3)

Publication Number Publication Date
JP2015519043A JP2015519043A (ja) 2015-07-09
JP2015519043A5 JP2015519043A5 (enExample) 2016-06-02
JP6470681B2 true JP6470681B2 (ja) 2019-02-13

Family

ID=46177101

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015505056A Expired - Fee Related JP6470681B2 (ja) 2012-04-10 2013-04-10 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ

Country Status (10)

Country Link
US (2) US20150057177A1 (enExample)
EP (1) EP2836838A4 (enExample)
JP (1) JP6470681B2 (enExample)
KR (1) KR20140143457A (enExample)
CN (2) CN107782901A (enExample)
AU (1) AU2013248138B2 (enExample)
CA (1) CA2869696A1 (enExample)
GB (1) GB201206323D0 (enExample)
MX (1) MX2014012192A (enExample)
WO (1) WO2013153524A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410226D0 (en) * 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same
CN106596494B (zh) * 2016-12-29 2019-05-10 青岛科技大学 一种基于荧光传感阵列的快速筛查早中晚期乳腺癌技术
GB201701572D0 (en) * 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
CN111458512A (zh) * 2019-01-21 2020-07-28 中国科学院分子细胞科学卓越创新中心 一种动脉粥样硬化生物标志物及其用途
JP7352937B2 (ja) * 2019-07-19 2023-09-29 公立大学法人福島県立医科大学 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット
CA3206126A1 (en) * 2021-01-15 2022-07-21 Universite De Fribourg Biomarkers for breast cancer detection

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990077146A (ko) * 1996-01-11 1999-10-25 길리스 스티브 유방암의 치료 및 진단용 조성물 및 방법
US20030138793A1 (en) * 2001-06-10 2003-07-24 Irm Llc, A Delaware Limited Liability Company Molecular signatures of commonly fatal carcinomas
WO2004106495A2 (en) * 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
KR20060031809A (ko) * 2003-06-09 2006-04-13 더 리젠츠 오브 더 유니버시티 오브 미시간 암 치료 및 진단용 조성물 및 방법
JP2005270093A (ja) * 2004-02-24 2005-10-06 Nippon Medical School 乳癌の術後予後予測に関与する遺伝子
US20080026950A1 (en) * 2004-02-24 2008-01-31 Mitsubishi Rayon Co., Ltd. Gene Relating to Estimation of Postoperative Prognosis for Breast Cancer
WO2006105642A1 (en) * 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
SG142186A1 (en) * 2006-10-20 2008-05-28 Agency Science Tech & Res Breast tumour grading
JP5196465B2 (ja) * 2007-04-24 2013-05-15 公益財団法人東京都農林水産振興財団 Ｍｍｐ遺伝子発現促進剤、および、コラーゲン分解促進剤
NZ562237A (en) * 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
GB0723179D0 (en) * 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
US8519116B2 (en) * 2008-04-29 2013-08-27 Siemens Healthcare Diagnostics Inc. Method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment
JP2010151800A (ja) * 2008-11-06 2010-07-08 Kumamoto Univ 生活習慣病及び／又は癌の診断剤
WO2010076322A1 (en) * 2008-12-30 2010-07-08 Siemens Healthcare Diagnostics Inc. Prediction of response to taxane/anthracycline-containing chemotherapy in breast cancer
WO2010088386A1 (en) * 2009-01-28 2010-08-05 University Of Notre Dame Du Lac Accelerated progression relapse test
WO2011063274A2 (en) * 2009-11-23 2011-05-26 Genomic Health, Inc. Methods to predict clinical outcome of cancer
WO2011065533A1 (ja) * 2009-11-30 2011-06-03 国立大学法人大阪大学 乳癌術前化学療法に対する感受性の判定方法

Also Published As

Publication number Publication date
AU2013248138A1 (en) 2014-11-27
WO2013153524A1 (en) 2013-10-17
EP2836838A1 (en) 2015-02-18
CN104508486B (zh) 2019-06-04
US20180284120A1 (en) 2018-10-04
CN107782901A (zh) 2018-03-09
WO2013153524A9 (en) 2014-03-13
CN104508486A (zh) 2015-04-08
GB201206323D0 (en) 2012-05-23
EP2836838A4 (en) 2016-03-30
CA2869696A1 (en) 2013-10-17
US20150057177A1 (en) 2015-02-26
AU2013248138B2 (en) 2019-01-17
KR20140143457A (ko) 2014-12-16
JP2015519043A (ja) 2015-07-09
MX2014012192A (es) 2015-05-11

Similar Documents

Publication Publication Date Title
Bouchal et al. Breast cancer classification based on proteotypes obtained by SWATH mass spectrometry
US20180284120A1 (en) Methods for determining a breast cancer-associated disease state and arrays for use in the methods
Olsson et al. Grading breast cancer tissues using molecular portraits
JP2021165745A (ja) 方法、アレイ、およびその使用
CN103038642B (zh) 方法、阵列及其用途
JP6674889B2 (ja) 前立腺がんに対するバイオマーカー検出における使用のための方法とアレイ
Kurbasic et al. Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases
Jain Innovations, challenges and future prospects of oncoproteomics
CA2950047A1 (en) Methods and arrays for use in the same
US20190284642A1 (en) Biomarkers for the prognosis and diagnosis of cancer
EP4314347A1 (en) Proteogenomic analysis of non-small cell lung cancer
JP2019032334A (ja) 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ
Dobhal et al. Multi-omics Approach Towards Cancer Therapy
Class et al. Patent application title: METHODS FOR DETERMINING A BREAST CANCER-ASSOCIATED DISEASE STATE AND ARRAYS FOR USE IN THE METHODS Inventors: Carl Arne Krister Borrebaeck (Lund, SE) Carl Arne Krister Borrebaeck (Lund, SE) Christer Lars Bertil Wingren (Sandby, SE)
WO2022216846A1 (en) Protein markers for estrogen receptor (er)-positive-like and estrogen receptor (er)-negative-like breast cancer
Zingde Proteomics for Cancer: Approaches and Challenges
Kulasingam et al. Proteomic and genomic technologies for biomarker discovery
Hayat Methods of cancer diagnosis, therapy, and prognosis: general overviews, head and neck cancer and thyroid cancer
Moskowitz et al. Oncogenomics/Proteomics of Head and Neck Cancers
Olsson Global Proteome Survey

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160330

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160330

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171107

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180425

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180605

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181003

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20181012

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190115

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190118

R150 Certificate of patent or registration of utility model

Ref document number: 6470681

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees